Delivery Order SPE2DB22D3501-SPE2DB24FUS85
- Not listed
- The federal contract award provides Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a Delivery Order valued at $30,687.90 to supply 4,566,487,325 units of Rifampin 300 mg capsules to the Defense Logistics Agency (DLA). This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,866.46, is a delivery order for the supply of 60 units of 300 mg Rifampin capsules. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,689.15, is a delivery order for the supply of 60-count packages of the 300 mg Rifampin capsule medication. The contract is not set aside and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,273.92 firm fixed price delivery order is for the supply of RIFAMPIN 150 MG CAPSULE 30S, a pharmaceutical product, in support of military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- This federal contract award is for the delivery of Rifampin 300 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,541.09. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are registered in...
- This federal contract award is a $5,421.42 firm fixed-price delivery order for the supply of RIFAMPIN 300 MG CAPSULE 60S medical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,341.59 Firm Fixed Price Delivery Order contract is for the supply of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $24,080.62 for the provision of 4560815694 RIFAMPIN 300 MG CAPSULE 60S. The award has a firm fixed price and an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $15,840.08 delivery order contract is for the supply of Rifampin 300 mg capsules. The contract has a firm fixed-price pricing type and a completion date of June 11, 2025. Amerisourcebergen Drug Corp is registered in the System for Award Management (SAM.gov) as a for-profit organization. The company holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The $2,810.16 firm-fixed-price contract has a completion date of January 11, 2023. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUS85Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora Inc., is a delivery order valued at $5,775.57 for the supply of Rifampin 150 mg capsules to the Defense Logistics Agency (DLA). The contract has a period of performance through February 28, 2024, and is a firm-fixed-price delivery order. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract. There is no set-aside designation associated with this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 2/27/24 |